ITEM 8.01 Other Events.

On June 22, 2009, Myriad Genetics, Inc. ("Myriad Genetics") issued an Information Statement relating to the previously announced spin-off and separation (the "Spin-off") of its wholly owned subsidiary, Myriad Pharmaceuticals, Inc. ("MPI"). Myriad Genetics expects to complete the Spin-off on June 30, 2009. The Information Statement contains a description of the terms of the Spin-off, including the procedures by which MPI common stock will be distributed, MPI, and MPI's common stock.

A copy of the Information Statement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Number Description
99.1 Information Statement dated June 18, 2009.

---